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Abstract
Background:   The hydrolysis of ATP and ADP by ecto-nucleoside triphosphate
diphosphohydrolase 1 (CD39) requires divalent cations, like Ca2+ and Mg2+. In spite of
considerable work, it is not clear whether divalent cations bind to the enzyme in the absence of
nucleotide or only as nucleotide-Me+2 complex. Here we study the protein ligands for Me+2.
Results:  When VO2+ was used as a substitute for Ca2+, the ATPase activity of soluble CD39 was
25% of that with Ca2+ as cofactor. Protein ligands of the VO2+-nucleotide complex bound to the
catalytic site of soluble CD39 were characterized by electron paramagnetic resonance (EPR)
spectroscopy. The EPR spectrum contained one species designated T with VO2+-AMPPNP as
ligand. Two species D1 and D2 were observed when VO2+-AMPCP was bound to soluble CD39.
The results suggest that species D1 and D2 represent the metal-ADP complexes at the catalytic
site of soluble CD39 corresponding to the intermediate formed during ATP hydrolysis and the
substrate for further hydrolysis, respectively.
Conclusions:  VO2+ can functionally substitute for Ca2+ as a cofactor of sCD39, and it produces
four different EPR features when bound in the presence of different nucleotides or in the absence
of nucleotide. The metal coordination for each conformation corresponding to each EPR species
is proposed, and the mechanism of sCD39 catalysis is discussed.
Background
Ecto-Nucleoside triphosphate diphosphohydrolases (E-
NTPDases, formerly called ecto-ATPases) hydrolyze nu-
cleotides in the presence of divalent cations and are in-
sensitive to inhibitors of P-type, F-type, and V-type
ATPases [1]. Three isoforms that differ in the ratio of AT-
Pase/ADPase activity are present on the cell surface [2]:
E-NTPDase1 with a ratio of 1, E-NTPDase2 with a ratio
of 10 and E-NTPDase3 with a ratio of 3–5. NTPDases are
important in many physiological processes like cell mo-
tility, adhesion, nonsynaptic information transfer, secre-
tion, regulation of hemostasis and ectokinases [1].
Understanding the enzymatic mechanisms of the NTP-
Dases will help description of their physiological func-
tions, and development of strategies to regulate the
functions of the enzymes.
The catalytic mechanism of NTPDases is not known even
though some basic facts of the catalysis have been estab-
lished. NTPDases do not form phosphorylated interme-
diates during catalysis, a conclusion also supported by
lack of vanadate sensitivity and Pi product inhibition [3–
6]. The catalytic reaction appears to be irreversible and
no partial reactions have been observed [7,8]. Divalent
cations like Ca2+ or Mg2+ are required for activity, and
maximal activity is reached when the concentrations of
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substrates and divalent cations are equal [1]. The specific
activities of NTPDases vary over a broad range from ten
thousand units for potato apyrase to less than one hun-
dred units for chicken gizzard ecto-ATPase [9,10]. Se-
quence comparisons indicate that most of NTPDases
contain five highly conserved regions, apyrase conserved
region, ACR1 – ACR5 [9,11]. However, the catalytic sites
have not been identified, although ACR1 and ACR4 have
been implicated in β - and γ -phosphate binding, respec-
tively [9].
E-NTPDase1 is also called CD39, as it was first described
as an antigen present on activated B and T lymphocytes.
Residues of ACR1 to ACR5 of CD39 have been mutated to
study the involvement of the ACR regions in catalysis.
E174 in ACR3 and S218 in ACR4 are required for catalyt-
ic function [12]. Substitution of H59 in ACR1 converted
CD39 into an ADPase in a quaternary structure depend-
ent manner [13]. Mutation of W187A in ACR3 affected
CD39 folding and translocation, while mutation of
W459A in ACR5 increased ATPase activity but dimin-
ished ADPase activity [14]. Mutations of D62 and G64 of
ACR1 and D219 and G221 of ACR4 demonstrated that
the nucleotide phosphate binding domains of NTPDases
are similar to those present in the actin/heat shock pro-
tein/sugar kinase superfamily [15]. These results suggest
that the conserved residues of the ACR1 to 5 regions are
involved in the catalytic mechanism of CD39.
The catalytic activity of CD39 is dependent on the pres-
ence of divalent cations. Since the interactions of Ca+2
and Mg+2 with proteins are difficult to study due to the
lack of spectroscopic properties, vanadyl (VIV=O)2+ has
been used as a probe of the ligands that compose Mg2+,
Ca2+, and Mn2+ binding sites of several proteins, includ-
ing carboxypeptidase [16], S-adenosylmethionine syn-
thetase [17,18], pyruvate kinase [19,20], and F1-ATPase
[21,22]. This cation specifically binds to divalent cation
binding sites of several enzymes, and in many cases
serves as a functional cofactor [23]. Vanadyl has one ax-
ial and four equatorial coordination sites relative to the
axis of the double-bounded oxygen, an arrangement that
is similar to that for Ca2+ and Mg2+. As it is known that
the A and g tensors derived from the EPR spectrum of
bound VO2+ are a direct measure of the nature of the
equatorial metal ligands [24], binding of VO2+ to CD39
could provide details about the catalytic mechanism of
CD39.
Recently we reported that a recombinant soluble CD39,
capable of hydrolyzing both ATP and ADP, was ex-
pressed and purified from insect cells [25]. Only one nu-
cleotide-binding site was identified on the purified
soluble CD39 in the presence of Ca2+ when non-hydro-
lysable nucleotide analogs were used. In this report, we
characterized the signals that were obtained from bound
VO2+ when ATP or ADP was present at the catalytic site
of the purified soluble CD39. The possible metal ligands
for VO+2 at the catalytic site are proposed and the cata-
lytic mechanism is discussed.
Results
Nucleotidase activity of purified soluble CD39 with VO2+ 
as cofactor
The ability of purified soluble CD39 to hydrolyze
VO2+ATP is shown in Figure 1. Soluble CD39 did not hy-
drolyze either ATP or ADP in the absence of VO2+ (Fig.
1A). When VO2+ was mixed with ATP at a ratio of 1:1, the
concentrations of both ADP and AMP increased and ATP
decreased as the incubation time was prolonged (Fig.
1B). The ATPase activity of sCD39 with VO2+ was about
25% of that with Ca2+ as a cofactor. Vanadyl is unstable
in aqueous solution at pH7.0 in the absence of chelator
and will precipitate out of solution as [VO(OH)2]n. The
rate of precipitation depends on the abundance and af-
finity of the chelator. This means that the actual VO2+
concentration was lower than 0.5 mM. This result indi-
cates that VO2+ can functionally substitute for Ca2+ as
cofactor for sCD39 nucleotidase activity.
Characterization of bound VO2+ ADPNP by CW-EPR
The parallel features of CW-EPR spectrum of bound
VO2+ in the presence of ADPNP, an ATP analog, are
shown in Figure 2a. This spectrum shows 51V hyperfine
splitting and the center of the parallel transitions from
molecules with the V=O bond oriented along the mag-
netic field (A||, g||) which are strong enough to tell the
nature of VO2+ equatorial ligands [22]. Of the eight tran-
sitions that result from the parallel oriented molecules,
the -7/2 ||, -5/2||, +3/2||, +5/2||, and +7/2|| transitions
(shown in the figures from left to right, respectively) do
not overlap with perpendicular transitions. The 51V hy-
perfine splitting spectra from molecules with V=O bond
perpendicular to the magnetic field (AŸ) are much
smaller and not shown here [21]. The intensity of -5/2||
peak is used as direct measurement of the amount of
bound VO2+, since this peak is the most intense peak in
the EPR spectrum that contains contribution only from
A|| but not AŸ [21,26]. In this study, the intensities of
each bound VO2+-EPR feature were normalized to 1 mg
of protein.
VO2+ bound as the VO2+-AMPPNP complex to sCD39
produced a strong spectrum characterized by A|| of
504.25 MHz and g|| of 1.9410 (Fig. 2b), called species T
(Table 1). The best fit of EPR species T to eq 1 is one equa-
torial nitrogen from an amino group and three equatorial
oxygen ligands from carboxyl or phosphate groups (Ta-
ble 2). This result is consistent with AMPPNP bindingBMC Biochemistry 2001, 2:9  http://www.biomedcentral.com/1471-2091/2/9
strongly to a single site on sCD39 in the presence of met-
al [25].
Characterization of EPR species from VO2+-AMPCP bound 
to sCD39
Figure 3a shows the parallel features of the EPR spec-
trum of sCD39 bound VO2+-AMPCP. Two sets of parallel
transitions were observed, and the derived A|| and g||
values are listed in Table 1. One set had A|| of 521.78 MHz
and g|| of 1.937, which is defined as species D1 (Fig. 3b).
The other set displayed A|| of 490.01 MHz and g|| of
1.9435, which is called species D2 (Fig. 3c). The intensity
of species D1 accounted for 11.4% of species T from
bound VO2+-AMPPNP, and the intensity of D2 account-
ed for 7.1% of species T. The intensity ratio of species D1
over D2 was 1.6.
In order to distinguish species D1 from D2, the sample
with VO2+-AMPCP bound to sCD39 was thawed and in-
cubated at room temperature for 30 minutes, and the
VO2+ EPR spectrum was collected again. As shown in
Figure 4a and 4b, either A|| or g|| values for both species
D1 and D2 were changed. The intensity of species D1 was
not changed as it accounted for 12.1% of the intensity of
species T of the bound VO2+-AMPPNP. However, the in-
tensity of species D2 was decreased dramatically, and it
accounted for only 0.1% of the intensity of species T. The
intensity ratio of D1 over D2 increased about 75 fold to
become 120.
Figure 1
ATP hydrolysis by sCD39 with VO2+ as cofactor analyzed by
HPLC. 2 µg of sCD39 was included in each assay. A. The
reaction was conducted in the presence of 0.5 mM ATP but
without VO2+. B. The reaction was initiated by adding 0.5
mM VO2+-ATP (1:1). ATP is represented as black diamonds;
ADP as a black square; and AMP as a black triangles;
Figure 2
Parallel regions of VO2+-EPR spectrum of VO2+-ADPNP
bound to sCD39. a. One mole equivalent of VO2+-ADPNP
was added to 2.8 mg of sCD39 as described in Experimental
Procedures. EPR conditions were as follows: field modulation
frequency, 100 kHz; modulation amplitude, 0.97 G; receive
gain, 2 ×  104; sweep time 5.243 s; time constant 1.28 ms;
micropower, 1.0 mW; microwave frequency 9.40386 GHz,
1000 scans; temperature; 125 K. b. Simulated spectrum was
generated by the program QPOWA with the experimental
conditions above and A|| = 504.25 MHz, g|| = 1.9410 for Spe-
cies T.BMC Biochemistry 2001, 2:9  http://www.biomedcentral.com/1471-2091/2/9
There are two sets of equatorial ligands that can fit well
the EPR species D1 according to Eq 1 (Table 2). One set
includes two equatorial oxygen from two water mole-
cules, one equatorial oxygen from a carboxyl group or
phosphate, and one equatorial nitrogen from an amino
group. The other set contains one equatorial oxygen
from water and three equatorial oxygens from carboxyl
groups or phosphate. The best fit for the EPR species D2
to eq 1 is one equatorial oxygen from a hydroxyl group
and three equatorial oxygens from carboxyl groups or
phosphate.
EPR characteristics of sCD39 bound VO2+-ATP
In order to capture the bound VO2+-EPR signal before
the enzyme completely turned over, sCD39 and VO2+-
ATP were mixed on ice, immediately transferred into the
EPR tube and frozen. The entire process took about 15
seconds. The parallel portion of the collected VO2+-EPR
spectrum is shown in Figure 5a. VO2+-ATP complex
bound to sCD39 produced an EPR spectrum with A|| of
489.5 MHz and g|| of 1.9455, which corresponded to spe-
cies D2 (Fig. 5b). The signal intensity from the bound
VO2+-nucleotide complex accounted only for 7.5% of
that of species T from bound non-hydrolysable VO2+-
ADPNP complex.
The same sample made from mixing VO2+-ATP and
sCD39 was incubated at room temperature for 30 min-
utes, then the VO2+-EPR spectrum was generated as
shown in Figures 4c and 4d. The EPR parameters de-
rived from this VO2+-EPR spectrum were 489.5 MHz for
A|| and 1.9455 for g|| respectively, which is consistent
with species D2. However, the signal intensity decreased
about 37.5 fold compared to that obtained before room
temperature incubation.
Table 1: Experimental signal intensity and 51 V-hyperfine parameters derived from the VO2+ bound to sCD39 under different 
conditions.
Intensity Experimental Parameters
Nucleotide Species
(% of VOADPNP) g|| A||
VOADPNP T 100 1.9410 504.25
VO2+ V 20.3 1.9460 486.00
D1 11.4 1.9370 521.78
VOAMPCP
D2 7.1 1.9435 490.01
VOAMPCP* D1 12.1 1.9350 521.78
VOATP D2 7.5 1.9455 489.5
VOATP* D2 0.2 1.9455 489.5
* Samples were incubated at room temperature for 30 minutes.
Table 2: Best fits of the 51 V-hyperfine parameters (Eq. 1) of VO2+ bound to various equatorial ligands of sCD39 under different 
conditions.
Calculated
Species Most Probable Equatorial Ligands
g|| A||
T 1.9445 504.25 RNH2 RCOO Pi Pi
D1 1.9390 520.95 H2OR C O O P i P i
D2 1.9435 490.01 ROH RCOO RCOO Pi
V 1.9500 485.36 ROH ROH H2OH 2OBMC Biochemistry 2001, 2:9  http://www.biomedcentral.com/1471-2091/2/9
Free VO2+ binding to sCD39 characterized by CD-EPR
Like other metals (Ca2+ and Mg2+), free VO2+ inhibited
the nucleotidase activities of sCD39 at high concentra-
tion (data not shown). VO2+ in the absence of any nucle-
otides was added to sCD39 at 1:1 molar ratio. The parallel
transitions of bound VO2+-EPR spectrum are shown in
Figure 6. The features derived from the VO2+-EPR spec-
trum were 486 MHz for A|| and 1.946 for g||, which was
designed as species V (Fig. 6b). The signal intensity of
bound VO2+ accounted for 20.3% of that from the bound
VO2+-ADPNP complex.
The best fit of equatorial ligands for species V according
to eq 1 is two equatorial oxygen from hydroxyl groups
and another two equatorial oxygen from two water mol-
ecules.
Discussion
Vanadyl has been used to estimate the types of groups
that serve as metal-ligands in F1-ATPase and other en-
zymes [16,18,19,21] because the g and A tensors of the
51V hyperfine couplings are approximately a linear com-
bination of tensors from each type of group that contrib-
utes an equatorial ligand [24,27]. By studying the EPR
spectra of bound VO2+ in the presence of different nucle-
otides, we show that the interaction of soluble CD39 with
ATP is different from that with ADP.
It is not surprising that VO2+ can functionally replace
Ca2+ in the hydrolysis of both ATP and ADP by soluble
CD39, although the enzymatic activity is about 25% of
that with Ca2+ as the cofactor, since F1-ATPase also hy-
drolyzes ATP at a decreased rate when VO2+ replaces
Mg2+[21].
Figure 3
Parallel regions of VO2+-EPR spectrum of VO2+-AMPCP
bound to sCD39. a. One mole equivalent of VO2+-AMPCP
was added to 6.5 mg of sCD39 prepared as in Experimental
Procedures. EPR conditions were as follows: field modulation
frequency, 100 kHz; modulation amplitude, 0.97 G; receive
gain, 2 ×  104; sweep time 5.243 s; time constant 1.28 ms;
micropower, 1.0 mW; microwave frequency 9.40677 GHz,
1600 scans; temperature; 125 K. b. Simulated spectrum was
generated by the program QPOWA with the experimental
conditions above and A|| = 521.78 MHz, g|| = 1.9370 for Spe-
cies D1. c. Simulated spectrum was generated by the pro-
gram QPOWA with the experimental conditions above and
A|| = 490.01 MHz, g|| = 1.9435 for Species D2.
Figure 4
Parallel -5/2|| region of VO2+-EPR spectra in the presence of
different nucleotides and conditions. a. One equivalent of a 1
: 1 mole ratio of VO2+-AMPPCP was added to sCD39, and
incubated on ice for 5 minutes. b. The sample from a was
thawed and incubated at room temperature for 30 minutes
before collecting data again. c. One equivalent of a 1 : 1 mole
ratio of VO2+-ATP was added to sCD39, and frozen immedi-
ately in liquid nitrogen. d. The sample from c was thawed and
incubated at room temperature for 30 minutes before col-
lecting data again.BMC Biochemistry 2001, 2:9  http://www.biomedcentral.com/1471-2091/2/9
The EPR features of VO2+ are able to reveal some details
about how CD39 hydrolyzes ATP and ADP. A single EPR
feature, species T, was observed when ADPNP (a non-
hydrolyzable analog of ATP) complexed with VO2+ was
bound to sCD39, which is consistent with the presence of
only one nucleotide binding site [25]. The g and A ten-
sors derived from species T are 1.9410 and 504.25 MHz
respectively, which can be fitted best with one amino
group and three groups combined from carboxyl and
phosphate groups as the equatorial ligands of the bound
VO2+ on sCD39. In accordance with metal-ATP complex
coordination on other enzymes that hydrolyze ATP, like
F1-ATPase [22,28], the γ - and β -phosphate of ATP most
likely bind to VO2+ while the third carboxyl group is con-
tributed by a side-chain of aspartate or glutamate of
sCD39. It is not unusual for the ε -amino group of lysine
to coordinate with metals in enzymes. It has been report-
ed that the amino group serves as one of VO2+ equatorial
ligands in CF1-ATPase [21], pyruvate kinase [19,20],
AdoMet synthetase [17,18], and carboxypeptidase [16].
Thus one amino group from lysine, one carboxyl group
from aspartate or glutamate, and two oxygens from the
phosphates of ADPNP serve as the equatorial ligands of
sCD39 bound VO2+ in the presence of ADPNP.
In the presence of AMPCP, bound VO2+ produced two
EPR features, species D1 and species D2 that are separat-
ed by about 30 MHz. As we have reported that sCD39 re-
leases intermediate ADP before ADP is further cleaved
during ATP hydrolysis [25], sCD39 probably has two
conformations that bind metal-ADP complexes, one is
the conformation that releases the ADP intermediate,
and another that recruits intermediate ADP back to the
enzyme for further hydrolysis to AMP. However, intact
CD39 does not release intermediate ADP during ATP hy-
drolysis, suggesting that there is only one ADP binding
site on each CD39 monomer in the intact protein [2,25].
The two EPR species observed with VO2+-AMPCP prob-
ably correspond to the two different conformations of
bound ADP at the same catalytic site on sCD39. The sig-
nal intensity of the bound VO2+-AMPCP EPR spectrum
indicates that species D1 is dominant over species D2. In
order to further assign species D1 and D2 to the two dif-
ferent conformations, two experiments were done (Fig.
5). Incubation of sCD39 with VO2+-AMPCP at room tem-
perature resulted in a dramatic decrease of the intensity
of species D2, while the signal intensity of species D1 re-
mained unchanged. These data indicate that VO2+-AM-
PCP was released from the conformation corresponding
to species D2; however, the conformation corresponding
to species D1 still had bound VO2+-AMPCP. More evi-
dence for two conformations of the enzyme was obtained
from the EPR spectra of bound VO2+-ATP. No species T
was found presumably because ATP was converted to
ADP before the sample was frozen. Only species D2 was
Figure 5
Parallel regions of VO2+-EPR spectrum of VO2+-ATP bound
to sCD39. a. One mole equivalent of VO2+-ATP was added
to 5.7 mg of sCD39 prepared as in Experimental Procedures.
EPR conditions were as follows: field modulation frequency,
100 kHz; modulation amplitude, 0.97 G; receive gain, 2 ×  104;
sweep time 5.243 s; time constant 1.28 ms; micropower, 1.0
mW; microwave frequency 9.40658 GHz, 3000 scans; tem-
perature; 125 K. b. Simulated spectrum was generated by the
program QPOWA with the experimental conditions above
and A|| = 489.5 MHz, g|| = 1.9455 for Species D2.
Figure 6
Parallel regions of VO2+-EPR spectrum of free VO2+ bound
to sCD39. a. One mole equivalent of free VO2+ was added
to 2.6 mg of sCD39 prepared as in Experimental Procedures.
EPR conditions were as follows: field modulation frequency,
100 kHz; modulation amplitude, 0.97 G; receive gain, 2 ×  104;
sweep time 5.243 s; time constant 1.28 ms; micropower, 1.0
mW; microwave frequency 9.40798 GHz, 3000 scans; tem-
perature; 125 K. b. Simulated spectrum was generated by the
program QPOWA with the experimental conditions above
and A|| = 486.00 MHz, g|| = 1.9460 for Species V.BMC Biochemistry 2001, 2:9  http://www.biomedcentral.com/1471-2091/2/9
observed and its intensity decreased as the incubation
time was prolonged. We suggest that species D2 corre-
sponds to the conformation that releases ADP as an in-
termediate product and species D1 corresponds to the
conformation that binds ADP as a substrate. The lower
signal intensities of species D1 and D2 compared to that
of species T suggest that the affinity of sCD39 for ADP or
its analog AMPCP is lower than that for the ATP analog
ADPNP, which is consistent with the result that only ATP
analogs were detected on sCD39 [25].
The calculated g|| and A|| values that best matched the
experimental values for species D2 suggest that one hy-
droxyl group and three oxygens derived from carboxyl
groups and phosphates are the equatorial ligands of
bound VO2+-ADP. Since the conformation correspond-
ing to species D2 is found in the presence of ATP and is
likely to be the conformation that releases bound VO+2-
ADP, it is likely that the VO+2 ligands are one phosphate
and two carboxyl groups [25]. When ADP is the substrate
and generates species D1, one water molecule and a com-
bination of three groups between carboxyl groups and
phosphates serve as the equatorial ligands of bound
VO2+ on sCD39. The probable combination of carboxyl
groups and phosphates for species D1 is one carboxyl
group and two phosphates since VO2+ complexes ADP
through two phosphates before VO2+-ADP is bound to
the enzyme.
The site directed mutagenesis studies on CD39 and other
members of the CD39 family give some hints about the
possible residues that serve as metal ligands at the cata-
lytic site of sCD39. The changes of D62 on ACR1, E174 on
ACR3, D213 (D219 in HB6) and S218 on ACR4 dramati-
cally decrease both ATPase and ADPase activities of
CD39 [12,15]. Figure 7 summarizes the possible coordi-
nation of Ca2+ from the data of species T, species D1, and
species D2 in the different situations of sCD39 catalysis.
The catalytic base attack results in cleavage of the γ -
phosphate of ATP, and one carboxyl group replaces the γ -
phosphate as a metal ligand (from species T to species
D2), which is accompanied by a swap of an amino group
with a hydroxyl group (S218?). This hydroxyl group
(S218?) probably interacts with the water molecule
through hydrogen bond in the conformation corre-
sponding to species D1 to hydrolyze ADP. The constant
carboxyl group that appears in all conformations of
sCD39 hydrolysis is likely contributed by D213 since it is
close to S218.
The results presented here also provide an explanation to
the free metal inhibition of CD39 catalytic activity. Free
VO2+ binds to sCD39 through two hydroxyl groups and
two water molecules that are hydrogen bonded to other
residues of sCD39. Once free VO2+ occupies the catalytic
Figure 7
Summary of the ligands at the metal coordination sites of
sCD39 during the catalytic reaction. The types of groups
shown as equatorial ligands were derived from the best fits
of 51V hyperfine values from Table 2. a. The metal ligands in
the presence of ADPNP (Species T) represent the conforma-
tion of ATP at the beginning of hydrolysis by sCD39. b. The
metal coordination sites in the presence of AMPCP (Species
D2) show the arrangement of the catalytic site prior to
release of ADP as an intermediate product. c. The metal
coordination sites in the presence of AMPCP (Species D1)
show the conformation of the catalytic site ready to hydro-
lyze ADP. d. Metal coordination in the absence of nucleotide
(Species V) showing the occupancy of the active site by free
metal with exclusion of nucleotide and consequent inhibition
of sCD39.BMC Biochemistry 2001, 2:9  http://www.biomedcentral.com/1471-2091/2/9
site, the enzyme has to either release the metal or correct
the conformation before the substrates are recruited
properly.
Conclusions
VO2+ can functionally substitute for Ca2+ as a cofactor
for sCD39. Four different EPR spectra are obtained for
VO2+ bound in the presence of different nucleotides and
in the absence of nucleotide. The protein ligands for
VO+2 in the presence of ATP are suggested to be carboxyl
and amino groups, while those in the presence of ADP
are probably carboxyl and hydroxyl groups. The mecha-
nism of sCD catalysis is discussed. These results will pro-
vide guides for further studies of the catalytic mechanism
of NTPDases.
Materials and Methods
Reagents
ATP, ADP, ADPNP, AMPCP were purchased from Sigma
(St. Louis, MO). Zeocin, High-Five medium were pur-
chased from Invitrogen (Carlsbad, CA).
Cell culture and preparation of soluble CD39
sCD39 transfected stable HighFive™ insect cells were
cultured as described by Chen and Guidotti [25]. Soluble
CD39 were purified as described [25] with some modifi-
cations. After concanavalin A-Sepharose 4B and nickel
affinity column chromatography, the ammonium sulfate
precipitated sCD39 was collected and resuspended in
about 50 µl of 40 mM Tris-HCl (pH7.5). This sample was
loaded on a Superose-12HR gel filtration column from
Pharmacia Biotech equilibrated with 40 mM Tris-HCl
(pH7.5). The fractions containing the major peak were
collected, and the solvent was changed to 20 mM Hepes
(pH8.0), 120 mM NaCl, 5 mM KCl with an YM30 centri-
con from Millipore. The final volume of the sample was
around 200 µl, and the concentration of sCD39 was
around 0.1 mM.
Concentrations of proteins were determined using DC
Protein Assay from BIO-RAD using the provided proto-
col.
Nucleotidase activity assay and nucleotide separation by 
HPLC
The reactions were carried out in 20 mM HEPES-Tris
(pH 7.0), 120 mM NaCl, and 5 mM KCl; they were started
by adding nucleotides at 37°C. After incubation for 15
minutes, the reactions were stopped with 2% perchloro-
acetic acid
Nucleotides were separated by HPLC on an anion ex-
change column (a 10 ×  0.46 mm SAX column from Rain-
in Instruments) based on the method of Hartwick and
Brown [29]. The low concentration buffer (A) was 0.08
M NH4H2PO4 (pH3.8), and the high concentration buff-
er (B) was 0.25 M NH4H2PO4 (pH4.95) with 8 mM KCl.
The gradient used was 4 min, 0–2.5% (B); 26 min, 2.5–
25% (B). Equilibration was done with buffer (A) for 10
minutes, and the flow rate was 1 ml/min.
Preparation of VO2+ solution
Vanadyl and nucleotide solution were prepared accord-
ing to Houseman et al. [21]. Dissolved molecular oxygen
was removed from solutions by purging with dry nitro-
gen gas. Stock vanadyl and nucleotide solution were
thawed on ice, and mixed at 1:1 molar ratio by vigorous
stirring. Then VO2+-nucleotide complexes were added to
purified sCD39 at 1:1 molar ratio, mixed, and incubated
for 5 minutes on ice before they were transferred into
EPR tubes. Once the samples were in EPR tubes, they
were immediately frozen in liquid nitrogen, and stored in
liquid nitrogen before using.
EPR Measurement
CW-EPR experiments were carried out at X-band (9
GHz) using a Bruker 300E spectrometer with a TE102
rectangular standard cavity and a liquid nitrogen flow
cryostat operating at 150 K. Simulations of these EPR
spectra were accomplished with the computer program
QPOWA [30,31]).
To estimate the types of groups that serve as equatorial
ligands to VO2+ in each condition, the observed values of
A|| derived from simulation of the EPR spectrum by
QPOWA were compared with the coupling constants ob-
tained from model studies [24,32] using:
A||calc = Σ  niA||i/4
where i represents the different types of equatorial lig-
and donor groups, ni (=1–4) is the number of ligands of
type i, and A||i is the measured coupling constant for
equatorial donor group i [24]. Similar equations were
used to calculated g|| from a given set of equatorial lig-
ands for comparison with those derived experimentally.
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